This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Javier, M. C.
Right arrow Articles by Nesin, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Javier, M. C.
Right arrow Articles by Nesin, M.
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
PEDIATRICS Vol. 112 No. 6 December 2003, pp. 1333-1337

Corrected End-Tidal Carbon Monoxide Closely Correlates With the Corrected Reticulocyte Count in Coombs’ Test-Positive Term Neonates

Maria Cristina Javier, MD, Alfred Krauss, MD and Mirjana Nesin, MD

From the Division of Neonatology, Department of Pediatrics, Weill Medical College of Cornell University, New York, New York

Objective. To evaluate clinical usefulness of corrected end-tidal carbon monoxide (ETCOc) measurements in healthy, term, Coombs’ test-positive neonates and correlate it to the corrected reticulocyte count (RC).

Methods. ETCOc and RC were determined (at 36 ± 12 hours of age) in 50 Coombs’ test-positive neonates and compared with the ETCOc values of 50 Coombs’ test-negative neonates.

Results. Fifty percent of Coombs’ test-positive infants had RCs <5% (within a normal range for a healthy newborn) and ETCOc = 1.8 ± 0.34 parts per million (ppm) and likely did not exhibit hemolysis. Among infants with elevated RCs, 72% had RCs between 5% and 8% and ETCOc = 2.77 ± 0.68 ppm, and 28% had RCs >8% and ETCOc = 4.52 ± 0.83 ppm. There was an almost linear correlation (r = 0.86) between the RC and the ETCOc among Coombs’ test-positive infants. The 50 Coombs’ test-negative infants had ETCOc = 1.6 ± 0.45 ppm. Serial ETCOc measurements were performed in 14 Coombs’ test-positive infants: in all but 1 infant ETCOc values declined over time.

Conclusions. There is a good correlation between ETCOc and RC in Coombs’ test-positive infants. ETCOc >2.5 ppm predicts a significant elevation of RC in 90% of Coombs’ test-positive infants.


Key Words: end-tidal carbon monoxide • reticulocyte count • infants • Coombs test

Abbreviations: RC, reticulocyte count • CO, carbon monoxide • ETCO, end-tidal CO • ETCOc, corrected ETCO • ppm, parts per million • ROC, receiver operator curve


Received for publication Aug 21, 2002; Accepted Mar 7, 2003.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Morimatsu, T. Takahashi, K. Maeshima, K. Inoue, T. Kawakami, H. Shimizu, M. Takeuchi, M. Yokoyama, H. Katayama, and K. Morita
Increased heme catabolism in critically ill patients: correlation among exhaled carbon monoxide, arterial carboxyhemoglobin, and serum bilirubin IX{alpha} concentrations
Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L114 - L119.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
C M Harrison and C C Andersen
Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease?
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2005; 90(1): F6 - F10.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. Kaplan, M. Herschel, C. Hammerman, J. D. Hoyer, and D. K. Stevenson
Hyperbilirubinemia Among African American, Glucose-6-Phosphate Dehydrogenase-Deficient Neonates
Pediatrics, August 1, 2004; 114(2): e213 - e219.
[Abstract] [Full Text] [PDF]